Table 2.
No. | Construct name | Residue | Substitution | Accessible surface area values | |||
---|---|---|---|---|---|---|---|
hC1pfVIII | HSA-C1 | 2R7E | 3CDZ | 4BDV | |||
1 | MHI-82 | MHI-128 | K2020 | E | 0.88 | 0.92 | 0.96 |
2 | T2023 | 0.16 | 0.29 | 0.19 | |||
3 | MHI-170 | MHI-171 | H2031 | R | 0.58 | 0.26 | 0.40 |
4 | MHI-83 | MHI-129 | E2066 | D | 0.80 | 0.51 | 0.42 |
5 | MHI-84 | MHI-130 | F2068 | H | 1.00 | 0.90 | 0.92 |
6 | MHI-85 | MHI-131 | K2085 | M | 0.29 | 0.31 | 0.26 |
7 | MHI-86 | MHI-132 | K2110 | R | 0.89 | 0.86 | 0.85 |
8 | MHI-87 | MHI-133 | K2111 | N | 0.64 | 0.76 | 0.69 |
9 | MHI-155 | MHI-172 | K2110/K2111 | R/N | — | — | — |
10 | T2114 | 0.49 | 0.17 | 0.22 | |||
11 | MHI-88 | MHI-134 | S2132 | A | 0.31 | 0.22 | 0.22 |
12 | I2145 | 0.30 | 0.32 | 0.25 | |||
13 | Q2087 | 0.02 | 0.06 | 0.02 | |||
14 | N/A | MHI-173 | R2090 | A | 0.62 | 0.69 | 0.76 |
15 | I2098 | 0.00 | 0.02 | 0.01 | |||
16 | N/A | MHI-174 | S2119 | A | 0.59 | 0.45 | 0.40 |
17 | N2129 | 0.14 | 0.06 | 0.03 | |||
18 | MHI-89 | MHI-135 | R2150 | H | 0.13 | 0.24 | 0.15 |
19 | P2153 | 0.11 | 0.16 | 0.10 | |||
20 | N/A | MHI-138 | R2159 | A | 0.21 | 0.05 | 0.08 |
21 | N/A | MHI-136 | Q2042 | A | 0.61 | 0.63 | 0.47 |
22 | N/A | MHI-137 | Y2043 | A | 0.30 | 0.39 | 0.46 |
23 | N/A | MHI-139 | K2065 | A | 0.27 | 0.67 | 0.63 |
24 | N/A | MHI-140 | P2067 | A | 0.47 | 0.61 | 0.64 |
25 | N/A | MHI-141 | Y2156 | A | 0.30 | 0.39 | 0.43 |
Overview of plasmid constructs encoding HSA-fVIII C1 domain and hC1pfVIII variants. The names of the plasmid constructs, the position and substitution of respective amino acid residue in the C1 domain (2020-2172), and the values for solvent-accessible surface area (ASA) are listed. ASA values were calculated for the BDD-fVIII structures 2R7E,36 3CDZ,37 and 4BDV,38 using the program ASAView (www.abren.net/asaview/).39 Rows 1-12, nonconserved residues among human and porcine fVIII C1 domains; rows 13-20, HA missense mutations in the C1 domain associated with reduced VWF binding25 and identified in the FVIII Variant Database (www.factorviii-db.org) by Chiu et al24; rows 21-22, residues additionally identified by site-directed mutagenesis to be involved in VWF binding26; rows 23-25, residues identified by eye screening of fVIII structures to be in close proximity to the crucial antibody binding residues E2066 and F2068. All mutant constructs supported expression and secretion of the respective protein similar to the native hC1pfVIII and HSA-hC1 constructs. N/A, not available.